NEO
Price:
$12.17
Market Cap:
$310.90M
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2004-03-16
Stock Exchange
NASDAQ
Ticker
NEO
According to NeoGenomics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -13.67. This represents a change of 355.69% compared to the average of -3.00 of the last 4 quarters.
The mean historical PE Ratio of NeoGenomics, Inc. over the last ten years is -8.34. The current -13.67 PE Ratio has changed 16.30% with respect to the historical average. Over the past ten years (40 quarters), NEO's PE Ratio was at its highest in in the December 2018 quarter at 166.59. The PE Ratio was at its lowest in in the September 2016 quarter at -479.37.
Average
-8.34
Median
-4.96
Minimum
-355.41
Maximum
280.24
Discovering the peaks and valleys of NeoGenomics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.52%
Maximum Annual PE Ratio = 280.24
Minimum Annual Increase = -190.12%
Minimum Annual PE Ratio = -355.41
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -5.30 | 14.86% |
| 2023 | -4.62 | 190.11% |
| 2022 | -1.59 | -98.38% |
| 2021 | -98.07 | -135.00% |
| 2020 | 280.24 | 281.73% |
| 2019 | 73.41 | -16.07% |
| 2018 | 87.48 | -124.61% |
| 2017 | -355.41 | 1.52% |
| 2016 | -21.93 | -41.66% |
| 2015 | -37.58 | -190.12% |
The current PE Ratio of NeoGenomics, Inc. (NEO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-3.84
5-year avg
34.13
10-year avg
-8.34
NeoGenomics, Inc.’s PE Ratio is less than Exagen Inc. (-9.30), less than MDxHealth S.A. (-5.38), less than Stereotaxis, Inc. (-9.34), less than Aclaris Therapeutics, Inc. (-2.74), less than Quanterix Corporation (-4.25), less than Sagimet Biosciences Inc. (-3.57), less than Sanara MedTech Inc. (-5.03), less than Arcturus Therapeutics Holdings Inc. (-3.71), less than Humacyte, Inc. (-10.58), greater than Alpha Teknova, Inc. (-14.19),
| Company | PE Ratio | Market cap |
|---|---|---|
| -9.30 | $169.75M | |
| -5.38 | $180.17M | |
| -9.34 | $225.93M | |
| -2.74 | $326.12M | |
| -4.25 | $359.67M | |
| -3.57 | $196.86M | |
| -5.03 | $194.79M | |
| -3.71 | $185.27M | |
| -10.58 | $185.66M | |
| -14.19 | $258.55M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeoGenomics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NeoGenomics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is NeoGenomics, Inc.'s PE Ratio?
How is the PE Ratio calculated for NeoGenomics, Inc. (NEO)?
What is the highest PE Ratio for NeoGenomics, Inc. (NEO)?
What is the 3-year average PE Ratio for NeoGenomics, Inc. (NEO)?
What is the 5-year average PE Ratio for NeoGenomics, Inc. (NEO)?
How does the current PE Ratio for NeoGenomics, Inc. (NEO) compare to its historical average?